FDA give unconditional IDE approval for Torus SFA stent graft study

Torus stent graft PQ Bypass has received full approval of its investigational device exemption (IDE) trial (TORUS 2) of its Torus stent graft, which is a novel stent graft platform designed for the treatment of peripheral arterial disease in the superficial femoral artery. By acquiring early FDA feedback through the presubmission process, [...]